As of April 2024 United Therapeutics has a market cap of $11.00 Billion. This makes United Therapeutics the world's 1499th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $11.00 B | 6.5% |
2023 | $10.33 B | -18.47% |
2022 | $12.67 B | 30.24% |
2021 | $9.73 B | 44.26% |
2020 | $6.74 B | 74.52% |
2019 | $3.86 B | -18.57% |
2018 | $4.74 B | -25.75% |
2017 | $6.39 B | 5.09% |
2016 | $6.08 B | -15.11% |
2015 | $7.16 B | 17.49% |
2014 | $6.09 B | 7.06% |
2013 | $5.69 B | 112.62% |
2012 | $2.67 B | -2.77% |
2011 | $2.75 B | -24.25% |
2010 | $3.63 B | 27.46% |
2009 | $2.85 B | 96.48% |
2008 | $1.45 B | -33.12% |
2007 | $2.17 B | 86.06% |
2006 | $1.16 B | -27.56% |
2005 | $1.61 B | 59.16% |
2004 | $1.01 B | 107.06% |
2003 | $0.48 B | 39.97% |
2002 | $0.34 B | 65.96% |
2001 | $0.21 B |
On Apr 28th, 2024 the market cap of United Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $143.82 B | 1,206.98% | ๐บ๐ธ USA |
Eli Lilly LLY | $697.39 B | 6,237.30% | ๐บ๐ธ USA |
Baxter BAX | $20.44 B | 85.74% | ๐บ๐ธ USA |
Gilead Sciences GILD | $81.57 B | 641.29% | ๐บ๐ธ USA |
Cardinal Health CAH | $25.10 B | 128.12% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.98 B | 663.21% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | $6.83 B | -37.91% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.64 B | 42.14% | ๐ฎ๐ฑ Israel |